Molecular genetics of Alzheimer's disease

Biological Psychiatry

Volumn 47, Issue 3, 2000, Pages 183-199

  St George Hyslop, Peter H ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

APP; A peptides; Presenilins; Secretases

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; EXON; HUMAN; MALE; MOLECULAR GENETICS; ONSET AGE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 21; DISEASE MODELS, ANIMAL; GENES, DOMINANT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEMBRANE PROTEINS; MUTATION, MISSENSE; PEPTIDE FRAGMENTS; PRESENILIN-1; PRESENILIN-2;

EID: 0033968306     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00301-7     Document Type: Review

References (154)

1. Alberts M.J., Graffagnino C., McClenny C., DeLong D., Strittmatter W., Saunders A.M., et al. ApoE genotype and survival from intracerebral haemorrhage. Lancet. 346:1995;575.
2. Arispe N., Pollard H.B., Rojas E. Giant multilevel cation channels formed by Alzheimer's disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes. Proc Natl Acad Sci U S A. 90:1993;10573-10577.
3. Baumeister R., Leimer U., Zweckbronner I., Jakubek C., Grunberg J., Haass C. Human presenilin-1, but not familial Alzheimer's disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing. Genes Funct. 1:1997;149-159.
4. Bird T.D., Levy-Lahad E., Poorkaj P., Sharma V., Nemens E., Lahad A., et al. Wide range in age of onset for chromosome 1 - related familial Alzheimer's disease. Ann Neurol. 40:1996;932-936.
5. Blacker D., Wilcox M.A., Laird N.M., Rodes L., Horvath S.M., Go R.C., et al. Alpha-2 macroglobulin is genetically associated with Alzheimer's disease. Nat Genet. 19:1998;357-360.
6. Borchelt D.R., Thinakaran G., Eckman C.B., Lee M.K., Davenport F., Ratovitsky T., et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta 1-42/1-40 ratio in vitro and in vivo. Neuron. 17:1996;1005-1013.
7. Boulianne G.L., Livne-Bar I., Humphreys J.M., Liang Y., Lin C., Rogaeva E., et al. Cloning and characterization of the Drosophila presenilin homologue. Neuroreport. 8:1997;1025-1029.
8. Breitner J.C., Silverman J.M., Mohs R.C., Davis K.L. Familial aggregation in Alzheimer's disease Comparison of risk among relatives of early- and late-onset cases, and among male and female relatives in successive generations . Neurology. 38:1988;207-212.
9. Brindle N., Song Y., Rogaeva E., Premkumar S., Levesque G., Yu G., et al. Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer's disease. Hum Mol Genet. 7:1998;933-935.
10. Brockhaus M., Grunberg J., Rohrig S., Loetscher H., Wittenburg N., Baumeister R., et al. Caspase-mediated cleavage is not required for the activity of presenilins in amyloidogenesis and NOTCH signaling. Neuroreport. 9:1998;1481-1486.
11. Bullido M.J., Artiga M.J., Recuero M., Sastre I., Garcia M.A., Aldudo J., et al. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat Genet. 18:1998;69-71.
12. Cai X.D., Golde T.E., Younkin S.G. Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science. 259:1993;514-516.
13. Capell A., Grunberg J., Pesold B., Diehlmann A., Citron M., Nixon R., et al. The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex. J Biol Chem. 273:1998;3205-3211.
14. Chartier-Harlin M.C., Crawford F., Houlden H., Warren A., Hughes D., Fidani L., et al. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature. 353:1991;844-846.
15. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A.Y., Seubert P., et al. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature. 360:1992;672-674.
16. Citron M., Westaway D., Xia W., Carlson G., Diehl T., Levesque G., et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med. 3:1997;67-72.
17. Clatworthy A.E., Gomez-Isla T., Rebeck G.W., Wallace R.B., Hyman B.T. Lack of association of a polymorphism in the low-density lipoprotein receptor-related protein gene with Alzheimer's disease. Arch Neurol. 54:1997;1289-1292.
18. Conlon R.A., Reaume A.G., Rossant J. Notch1 is required for the coordinate segmentation of somites. Development. 121:1995;1533-1545.
19. Cook D.G., Forman M.S., Sung J.C., Leight S., Kolson D.L., Iwatsubo T., et al. Alzheimer's A beta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nat Med. 3:1997;1021-1023.
20. Corder E.H., Saunders A.M., Risch N.J., Strittmatter W.J., Schmechel D.E., Gaskell P.C. Jr, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer's disease. Nat Genet. 7:1994;180-184.
21. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
22. Crawford F., Fallin D., Suo Z., Abdullah L., Gold M., Gauntlett A., et al. The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations. Neurosci Lett. 249:1998;115-118.
23. Davis J.A., Naruse S., Chen H., Eckman C., Younkin S., Price D.L., et al. An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos. Neuron. 20:1998;603-609.
24. De Strooper B., Beullens M., Contreras B., Levesque L., Craessaerts K., Cordell B., et al. Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins. J Biol Chem. 272:1997;3590-3598.
25. De Strooper B., Saftig P., Craessaerts K., Vanderstichele H., Guhde G., Annaert W., et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature. 391:1998;387-390.
26. Doan A., Thinakaran G., Borchelt D.R., Slunt H.H., Ratovitsky T., Podlisny M., et al. Protein topology of presenilin 1. Neuron. 17:1996;1023-1030.
27. Duff K., Eckman C., Zehr C., Yu X., Prada C.M., Perez-tur J., et al. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature. 383:1996;710-713.
28. Eckman C.B., Mehta N.D., Crook R., Perez-tur J., Prihar G., Pfeiffer E., et al. A new pathogenic mutation in the βAPP gene (1716V) increases the relative proportion of A beta 42 (43). Hum Mol Genet. 6:1997;2087-2089.
29. Fallin D., Kundtz A., Town T., Gauntlett A.C., Duara R., Barker W., et al. No association between the low density lipoprotein receptor-related protein (LRP) gene and late-onset Alzheimer's disease in a community-based sample. Neurosci Lett. 233:1997;145-147.
30. Farrer L.A., Myers R.H., Connor L., Cupples L.A., Growdon J.H. Segregation analysis reveals evidence of a major gene for Alzheimer's disease. Am J Hum Genet. 48:1991;1026-1033.
31. Fraser P.E., Levesque G., Yu G., Mills L.R., Thirlwell J., Frantseva M., et al. Presenilin 1 is actively degraded by the 26S proteasome. Neurobiol Aging. 19:(suppl 1):1998;S19-S21.
32. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 349:1991;704-706.
33. Golde T.E., Estus S., Younkin L.H., Selkoe D.J., Younkin S.G. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science. 255:1992;728-730.
34. Goldgaber D., Lerman M.I., McBride O.W., Saffiotti U., Gajdusek D.C. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science. 235:1987;877-880.
35. Grunberg J., Walter J., Loetscher H., Deuschle U., Jacobsen H., Haass C. Alzheimer's disease associated presenilin-1 holoprotein and its 18-20 kDa C-terminal fragment are death substrates for proteases of the caspase family. Biochemistry. 37:1998;2263-2270.
36. Haass C., Hung A.Y., Selkoe D.J., Teplow D.B. Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor. J Biol Chem. 269:1994;17741-17748.
37. Haass C., Koo E.H., Mellon A., Hung A.Y., Selkoe D.J. Targeting of cell-surface beta-amyloid precursor protein to lysosomes Alternative processing into amyloid-bearing fragments . Nature. 357:1992;500-503.
38. Haass C., Lemere C.A., Capell A., Citron M., Seubert P., Schenk D., et al. The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathway. Nat Med. 1:1995;1291-1296.
39. Haass C., Schlossmacher M.G., Hung A.Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B.L., et al. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature. 359:1992;322-325.
40. Haines J.L., Pritchard M.L., Saunders A.M., Schildkraut J.M., Growdon J.H., Gaskell P.C., et al. No genetic effect of alpha1-antichymotrypsin in Alzheimer's disease. Genomics. 33:1996;53-56.
41. Hartmann T., Bieger S.C., Bruhl B., Tiernari P.J., Ida N., Allsop D., et al. Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides. Nat Med. 3:1997;1016-1020.
42. Hendrie H.C., Hall K.S., Hui S., Unverzagt F.W., Yu C.E., Lahiri D.K., et al. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann Neurol. 37:1995;118-120.
43. Hendriks L., van Duijn C.M., Cras P., Cruts M., Van Hul W., van Harskamp F., et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet. 1:1992;218-221.
44. Herreman A., Hartmann D., Annaert W., Saftig P., Craessaerts K., Serneels L., et al. Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc Natl Acad Sci U S A. 96:1999;11872-11877.
45. Heyman A., Wilkinson W.E., Stafford J.A., Helms M.J., Sigmon A.H., Weinberg T. Alzheimer's disease A study of epidemiological aspects . Ann Neurol. 15:1984;335-341.
46. Hollenbach E., Ackermann S., Hyman B.T., Rebeck G.W. Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease. Neurology. 50:1998;1905-1907.
47. Huang D.Y., Goedert M., Jakes R., Weisgraber K.H., Garner C.C., Saunders A.M., et al. Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c Implications for Alzheimer's disease . Neurosci Lett. 182:1994;55-58.
48. Huang D.Y., Weisgraber K.H., Goedert M., Saunders A.M., Roses A.D., Strittmatter W.J. ApoE3 binding to tau tandem repeat I is abolished by tau serine262 phosphorylation. Neurosci Lett. 192:1995;209-212.
49. Jarrett J.T., Lansbury P.T. Jr. Seeding "one-dimensional crystallization" of amyloid A pathogenic mechanism in Alzheimer's disease and scrapie? Cell. 73:1993;1055-1058.
50. Kamboh M.I., Ferrell R.E., DeKosky S.T. Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene. Neurosci Lett. 244:1998;65-68.
51. Kamboh M.I., Sanghera D.K., Ferrell R.E., DeKosky S.T. APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism. Nat Genet. 10:1995;486-488.
52. Kang D.E., Saitoh T., Chen X., Xia Y., Masliah E., Hansen L.A., et al. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology. 49:1997;56-61.
53. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:1987;733-736.
54. Karlinsky H., Vaula G., Haines J.L., Ridgley J., Bergeron C., Mortilla M., et al. Molecular and prospective phenotypic characterization of a pedigree with familial Alzheimer's disease and a missense mutation in codon 717 of the beta-amyloid precursor protein gene. Neurology. 42:1992;1445-1453.
55. Katzman R., Kawas C. The epidemiology of dementia and Alzheimer's disease. Terry R.D., Katzman R., Bick K.L. Alzheimer's Disease. 1994;105-122 Raven, New York.
56. Kim T.W., Pettingell W.H., Jung Y.K., Kovacs D.M., Tanzi R.E. Alternative cleavage of Alzheimer's-associated presenilins during apoptosis by a caspase-3 family protease. Science. 277:1997;373-376.
57. Kounnas M.Z., Moir R.D., Rebeck G.W., Bush A.I., Argraves W.S., Tanzi R.E., et al. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell. 82:1995;331-340.
58. Kruglyak L., Daly M.J., Reeve-Daly M.P., Lander E.S. Parametric and nonparametric linkage analysis A unified multipoint approach . Am J Hum Genet. 58:1996;1347-1363.
59. Kwok J.B., Taddei K., Hallupp M., Fisher C., Brooks W.S., Broe G.A., et al. Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype. Neuroreport. 8:1997;1537-1542.
60. Lambert J.C., Pasquier F., Cottel D., Frigard B., Amouyel P., Chartier-Harlin M.C. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease. Hum Mol Genet. 7:1998;533-540.
61. Lautenschlager N.T., Cupples L.A., Rao V.S., Auerbach S.A., Becker R., Burke J., et al. Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study What is in store for the oldest old? Neurology. 46:1996;641-650.
62. Lee M.K., Slunt H.H., Martin L.J., Thinakaran G., Kim G., Gandy S.E., et al. Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues. J Neurosci. 16:1996;7513-7525.
63. Lee S.J., Liyanage U., Bickel P.E., Xia W., Lansbury P.T. Jr, Kosik K.S. A detergent-insoluble membrane compartment contains A beta in vivo. Nat Med. 4:1998;730-734.
64. Lehmann D.J., Johnston C., Smith A.D. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease. Hum Mol Genet. 6:1997;1933-1936.
65. Lehmann S., Chiesa R., Harris D.A. Evidence for a six-transmembrane domain structure of presenilin 1. J Biol Chem. 272:1997;12047-12051.
66. Lendon C.L., Talbot C.J., Craddock N.J., Han S.W., Wragg M., Morris J.C., et al. Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population. Neurosci Lett. 222:1997;187-190.
67. Levitan D., Doyle T.G., Brousseau D., Lee M.K., Thinakaran G., Slunt H.H., et al. Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc Natl Acad Sci U S A. 93:1996;14940-14944.
68. Levitan D., Greenwald I. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature. 377:1995;351-354.
69. Levy E., Carman M.D., Fernandez-Madrid I.J., Power M.D., Lieberburg I., van Duinen S.G., et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science. 248:1990;1124-1126.
70. Levy-Lahad E., Wijsman E.M., Nemens E., Anderson L., Goddard K.A., Weber J.L., et al. A familial Alzheimer's disease locus on chromosome 1. Science. 269:1995;970-973.
71. L'Hernault S.W., Arduengo P.M. Mutation of a putative sperm membrane protein in Caenorhabditis elegans prevents sperm differentiation but not its associated meiotic divisions. J Cell Biol. 119:1992;55-68.
72. Li X., Greenwald I. Membrane topology of the C. elegans SEL-12 presenilin. Neuron. 17:1996;1015-1021.
73. Lorenzo A., Yankner B.A. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci U S A. 91:1994;12243-12247.
74. Maestre G., Ottman R., Stern Y., Gurland B., Chun M., Tang M.X., et al. Apolipoprotein E and Alzheimer's disease Ethnic variation in genotypic risks . Ann Neurol. 37:1995;254-259.
75. Martins R.N., Turner B.A., Carroll R.T., Sweeney D., Kim K.S., Wisniewski H.M., et al. High levels of amyloid-beta protein from S182 (Glu246) familial Alzheimer's cells. Neuroreport. 7:1995;217-220.
76. Masliah E., Mallory M., Ge N., Alford M., Veinbergs I., Roses A.D. Neurodegeneration in the central nervous system of apoE-deficient mice. Exp Neurol. 136:1995;107-122.
77. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R.E. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci. 12:1992;376-389.
78. Mattson M.P., Goodman Y. Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium. Brain Res. 676:1995;219-224.
79. Mayeux R., Ottman R., Maestre G., Ngai C., Tang M.X., Ginsberg H., et al. Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease. Neurology. 45:1995;555-557.
80. Montoya S.E., Aston C.E., DeKosky S.T., Kamboh M.I., Lazo J.S., Ferrell R.E. Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease. Nat Genet. 18:1998;211-212.
81. Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., et al. A pathogenic mutation for probable Alzheimer's disease in the βAPP gene at the N-terminus of beta-amyloid. Nat Genet. 1:1992;345-347.
82. Murrell J., Farlow M., Ghetti B., Benson M.D. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science. 254:1991;97-99.
83. Nacmias B., Latorraca S., Piersanti P., Forleo P., Piacentini S., Bracco L., et al. ApoE genotype and familial Alzheimer's disease A possible influence on age of onset in βAPP717 Val→Ile mutated families . Neurosci Lett. 183:1995;1-3.
84. Naruse S., Igarashi S., Kobayaski H., Aoki K., Inuzuka T., Kaneko K., et al. Missense mutation Val-Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease. Lancet. 337:1991;978-979.
85. Nathan B.P., Bellosta S., Sanan D.A., Weisgraber K.H., Mahley R.W., Pitas R.E. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science. 264:1994;850-852.
86. Nathan B.P., Chang K.C., Bellosta S., Brisch E., Ge N., Mahley R.W., et al. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J Biol Chem. 270:1995;19791-19799.
87. Newman M.F., Croughwell N.D., Blumenthal J.A., Lowry E., White W.D., Spillane W., et al. Predictors of cognitive decline after cardiac operation. Ann Thorac Surg. 59:1995;1326-1330.
88. Nishimura M., Yu G., Levesque G., Zhang D.M., Ruel L., Chen F., et al. Presenilin mutations associated with Alzheimer's disease cause defective intracellular trafficking of beta-catenin, a component of the presenilin protein complex. Nat Med. 5:1999;164-169.
89. Okamoto T., Takeda S., Murayama Y., Ogata E., Nishimoto I. Ligand-dependent G protein coupling function of amyloid transmembrane precursor. J Biol Chem. 270:1995;4205-4208.
90. Okuizumi K., Onodera O., Namba Y., Ikeda K., Yamamoto T., Seki K., et al. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nat Genet. 11:1995;207-209.
91. Olichney J.M., Hansen L.A., Galasko D., Saitoh T., Hofstetter C.R., Katzman R., et al. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology. 47:1996;190-196.
92. Perez-Tur J., Froelich S., Prihar G., Crook R., Baker M., Duff K., et al. A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport. 7:1995;297-301.
93. Pericak-Vance M.A., Bass M.P., Yamaoka L.H., Gaskell P.C., Scott W.K., Terwedow H.A., et al. Complete genomic screen in late-onset familial Alzheimer's disease. Evidence for a new locus on chromosome 12. JAMA. 278:1997;1237-1241.
94. Pericak-Vance M.A., Bebout J.L., Gaskell P.C. Jr, Yamaoka L.H., Hung W.Y., Alberts M.J., et al. Linkage studies in familial Alzheimer's disease Evidence for chromosome 19 linkage . Am J Hum Genet. 48:1991;1034-1050.
95. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by beta-amyloid peptides in vitro The role of peptide assembly state . J Neurosci. 13:1993;1676-1687.
96. Podlisny M.B., Citron M., Amarante P., Sherrington R., Xia W., Zhang J., et al. Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer's brain tissue. Neurobiol Dis. 3:1997;325-337.
97. Qian S., Jiang P., Guan X.M., Singh G., Trumbauer M.E., Yu H., et al. Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates Abeta 1-42/43 expression. Neuron. 20:1998;611-617.
98. Rebeck G.W., Perls T.T., West H.L., Sodhi P., Lipsitz L.A., Hyman B.T. Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology. 44:1994;1513-1516.
99. Robakis N.K. Expression studies of the gene encoding the Alzheimer's disease and Down syndrome amyloid peptide. Swann J.W. Disorders of the Developing Nervous System Changing Views on Their Origins, Diagnoses and Treatments . 1988;183-193 Alan R. Liss, New York.
100. Rocca W.A., Amaducci L.A., Schoenberg B.S. Epidemiology of clinically diagnosed Alzheimer's disease. Ann Neurol. 19:1986;415-424.
101. Rogaeva E., Premkumar S., Song Y., Sorbi S., Brindle N., Paterson A., et al. Evidence for an Alzheimer's disease susceptibility locus on chromosome 12 and for further locus heterogeneity. JAMA. 280:1998;614-618.
102. Rogaeva E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y., et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 376:1995;775-778.
103. Roses A.D., Saunders A. Head injury, amyloid beta and Alzheimer's disease. Nat Med. 1:1995;603-604.
104. Sato S, Kamino K, Miki T, Doi A, Ii K, St George-Hyslop PH, et al (1998): Splicing mutation of presenilin-1 gene for early-onset familial Alzheimer's disease. Hum Mutat Suppl 1:S91-S94.
105. Saunders A.M., Strittmatter W.J., Schmechel D., St George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
106. Schellenberg G.D., Bird T.D., Wijsman E.M., Orr H.T., Anderson L., Nemens E., et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science. 258:1992;668-671.
107. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and βAPP mutations linked to familial Alzheimer's disease. Nat Med. 2:1996;864-870.
108. Schmechel D.E., Saunders Am, Strittmatter W.J., Crain B.J., Hulette C.M., Joo S.H., et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc Natl Acad Sci U S A. 90:1993;9649-9653.
109. Scott W.K., Growdon J.H., Roses A.D., Haines J.L., Pericak-Vance M.A. Presenilin-1 polymorphism and Alzheimer's disease. Lancet. 347:1996;1186-1187.
110. Selkoe D.J. Normal and abnormal biology of the beta-amyloid precursor protein. Annu Rev Neurosci. 17:1994;489-517.
111. Shen J., Bronson R.T., Chen D.F., Xia W., Selkoe D.J., Tonegawa S. Skeletal and CNS defects in presenilin-1-deficient mice. Cell. 89:1997;629-639.
112. Sherrington R., Froelich S., Sorbi S., Campion D., Chi H., Rogaeva E.A., et al. Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum Mol Genet. 5:1996;985-988.
113. Sherrington R., Rogaeva E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
114. Shoji M., Golde T.E., Ghiso J., Cheung T.T., Estus S., Shaffer L.M., et al. Production of the Alzheimer's amyloid beta protein by normal proteolytic processing. Science. 258:1992;126-129.
115. Silverman J.M., Li G., Zaccario M.L., Smith C.J., Schmeidler J., Mohs R.C., et al. Patterns of risk in first-degree relatives of patients with Alzheimer's disease. Arch Gen Psychiatry. 51:1994;577-586.
116. Song Y.Q., Rogaeva E., Premkumar S., Brindle N., Kawarai T., Orlacchio A., et al. Absence of association between Alzheimer's disease and the -491 regulatory region polymorphism of APOE. Neurosci Lett. 250:1998;189-192.
117. Sorbi S., Nacmias B., Forleo P., Piacentini S., Latorraca S., Amaducci L. Epistatic effect of βAPP717 mutation and apolipoprotein E genotype in familial Alzheimer's disease. Ann Neurol. 38:1995;124-127.
118. Spielman R.S., Ewens W.J. A sibship test for linkage in the presence of association The sib transmission/disequilibrium test . Am J Hum Genet. 62:1998;450-458.
119. St George-Hyslop P. Genetics of Alzheimer's disease. Markesbery W. Neuropathology of Dementing Diseases. 1997;Edward Arnold, London.
120. St George-Hyslop P.H., Haines J., Rogaeva E., Mortilla M., Vaula G., Pericak-Vance M., et al. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat Genet. 2:1992;330-334.
121. St George-Hyslop P.H., Haines J.L., Farrer L.A., Polinsky R., Van Broeckhoven C., Goate A., et al. Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. FAD Collaborative Study Group. Nature. 347:1990;194-197.
122. St George-Hyslop P.H., McLachlan D.C., Tsuda T., Rogaeva E., Karlinsky H., Lippa C.F., et al. Alzheimer's disease and possible gene interaction. Science. 263:1994;537.
123. Strittmatter W.J., Saunders A.M., Goedert M., Weisgraber K.H., Dong L.M., Jakes R., et al. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau Implications for Alzheimer's disease . Proc Natl Acad Sci U S A. 91:1994;11183-11186.
124. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., et al. Apolipoprotein E High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease . Proc Natl Acad Sci U S A. 90:1993;1977-1981.
125. Strittmatter W.J., Weisgraber K.H., Huang D.Y., Dong L.M., Salvesen G.S., Pericak-Vance M., et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide Isoform-specific effects and implications for late-onset Alzheimer's disease . Proc Natl Acad Sci U S A. 90:1993;8098-8102.
126. Suzuki N., Cheung T.T., Cai X.D., Odaka A., Otvos L. Jr, Eckman C., et al. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science. 264:1994;1336-1340.
127. Tamaoka A., Fraser P.E., Ishii K., Sahara N., Ozawa K., Ikeda M., et al. Amyloid-beta-protein isoforms in brain of subjects with PS1-linked, beta APP-linked and sporadic Alzheimer's disease. Brain Res Mol Brain Res. 56:1998;178-185.
128. Tang M.X., Stern Y., Marder K., Bell K., Gurland B., Lantigua R., et al. The APOE-epsilon4 allele and the risk of Alzheimer's disease among African Americans, whites, and Hispanics. JAMA. 279:1998;751-755.
129. Tanzi R.E., Gusella J.F., Watkins P.C., Bruns G.A., St George-Hyslop P.H., Van Keuren M.L., et al. Amyloid beta-protein gene cDNA, mRNA distribution, and genetic linkage near the Alzheimer's locus . Science. 235:1987;880-884.
130. Thinakaran G., Borchelt D.R., Lee M.K., Slunt H.H., Spitzer L., Kim G., et al. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron. 17:1996;181-190.
131. Thinakaran G., Regard J.B., Bouton C.M., Harris C.L., Price D.L., Borchelt D.R., et al. Stable association of presenilin derivatives and absence of presenilin interactions with βAPP. Neurobiol Dis. 4:1998;438-453.
132. Tomita T., Tokuhiro S., Hashimoto T., Aiba K., Saido T.C., Maruyama K., et al. Molecular dissection of domains in mutant presenilin 2 that mediate overproduction of amyloidogenic forms of amyloid beta peptides. Inability of truncated forms of PS2 with familial Alzheimer's disease mutation to increase secretion of Abeta42. J Biol Chem. 273:1998;21153-21160.
133. Town T., Paris D., Fallin D., Duara R., Barker W., Gold M., et al. The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease Independent risk and linkage disequilibrium with the known APOE polymorphism . Neurosci Lett. 252:1998;95-98.
134. Tysoe C., Whittaker J., Xuereb J., Cairns N.J., Cruts M., Van Broeckhoven C., et al. A presenilin-1 truncating mutation is present in two cases with autopsy-confirmed early-onset Alzheimer's disease. Am J Hum Genet. 62:1998;70-76.
135. Van Broeckhoven C. Presenilins and Alzheimer's disease. Nat Genet. 11:1995;230-232.
136. Van Broeckhoven C., Backhovens H., Cruts M., De Winter G., Bruyland M., Cras P., et al. Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3. Nat Genet. 2:1992;335-339.
137. Van Broeckhoven C., Backhovens H., Cruts M., Martin J.J., Crook R., Houlden H., et al. APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease. Neurosci Lett. 169:1994;179-180.
138. van Duijn C.M., de Knijff P., Cruts M., Wehnert A., Havekes L.M., Hofman A., et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet. 7:1994;74-78.
139. Vassar R., Bennett B.D., Babu-Khan S., Kahn S., Mendiaz E.A., Denis P., et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 286:1999;735-741.
140. Vito P., Ghayur T., D'Adamio L. Generation of anti-apoptotic presenilin-2 polypeptides by alternative transcription, proteolysis, and caspase-3 cleavage. J Biol Chem. 272:1997;28315-28320.
141. Walter J., Capell A., Grunberg J., Pesold B., Schindzielorz A., Prior R., et al. The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum. Mol Med. 2:1996;673-691.
142. Wavrant-DeVrieze F., Perez-Tur J., Lambert J.C., Frigard B., Pasquier F., Delacourte A., et al. Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease. Neurosci Lett. 227:1997;68-70.
143. Weidemann A., Paliga K., Durrwang U., Czech C., Evin G., Masters C.L., et al. Formation of stable complexes between two Alzheimer's disease gene products Presenilin-2 and beta-amyloid precursor protein . Nat Med. 3:1997;328-332.
144. Wild-Bode C., Yamazaki T., Capell A., Leimer U., Steiner H., Ihara Y., et al. Intracellular generation and accumulation of amyloid beta-peptide terminating at amino acid 42. J Biol Chem. 272:1997;16085-16088.
145. Wisniewski T., Ghiso J., Frangione B. Peptides homologous to the amyloid protein of Alzheimer's disease containing glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem Biophys Res Commun. 180:1991;1528.
146. Wong P.C., Zheng H., Chen H., Becher M.W., Sirinathsinghji D.J., Trumbauer M.E., et al. Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature. 87:1997;288-292.
147. Woodward R., Singleton A.B., Gibson A.M., Edwardson J.A., Morris C.M. LRP gene and late-onset Alzheimer's disease. Lancet. 352:1998;239-240.
148. Wragg M., Hutton M., Talbot C. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Alzheimer's Disease Collaborative Group. Lancet. 347:1996;509-512.
149. Xia W., Zhang J., Perez R., Koo E.H., Selkoe D.J. Interaction between amyloid precursor protein and presenilins in mammalian cells Implications for the pathogenesis of Alzhei-mer's disease . Proc Natl Acad Sci U S A. 94:1997;8208-8213.
150. Yamatsuji T., Matsui T., Okamoto T., Komatsuzaki K., Takeda S., Fukumoto H., et al. G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of βAPP. Science. 272:1996;1349-1352.
151. Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid beta protein Reversal by tachykinin neuropeptides . Science. 250:1990;279-282.
152. Yu G., Chen F., Levesque G., Nishimura M., Zhang D.M., Levesque L., et al. The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin. J Biol Chem. 273:1998;16470-16475.
153. Zhang W., Han S.W., McKeel D.W., Goate A., Wu J.Y. Interaction of presenilins with the filamin family of actin-binding proteins. J Neurosci. 18:1998;914-922.
154. Zhou J., Liyanage U., Medina M., Ho C., Simmons A.D., Lovett M., et al. Presenilin 1 interaction in the brain with a novel member of the Armadillo family. Neuroreport. 8:1997;2085-2090.